David Lawrence, Chief Financial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 5,000 shares at $30.00 ($150K) on 2010-02-02, disclosed to the SEC on 2010-02-03.
Scheduled sale ($150k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |